Showing 1 - 7 results of 7 for search 'Tao-Lan Zhang', query time: 0.04s Refine Results
  1. 1
    Correction: Shao et al. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 350

    Correction: Shao et al. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 350 by Ying-Ying Shao, Tao-Lan Zhang, Lan-Xiang Wu, He-Cun Zou, Shuang Li, Jin Huang, Hong-Hao Zhou

    Published 2021-11-01
    Get full text
    Article
  2. 2
    A four‐factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma

    A four‐factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma by Ming‐Xiang Zou, Yue Pan, Wei Huang, Tao‐Lan Zhang, David Escobar, Xiao‐Bin Wang, Yi Jiang, Xiao‐Ling She, Guo‐Hua Lv, Jing Li

    Published 2020-03-01
    Get full text
    Article
  3. 3
    Incidence and Risk Factors for Cerebrovascular-Specific Mortality in Patients with Colorectal Cancer: A Registry-Based Cohort Study Involving 563,298 Patients

    Incidence and Risk Factors for Cerebrovascular-Specific Mortality in Patients with Colorectal Cancer: A Registry-Based Cohort Study Involving 563,298 Patients by Zhi-Hui Dai, Ming Tang, Yun-Liang Chen, Tao-Lan Zhang, Jing Li, Guo-Hua Lv, Yi-Guo Yan, Zhi-Hua Ouyang, Wei Huang, Ming-Xiang Zou

    Published 2022-04-01
    Get full text
    Article
  4. 4
    Clinicopathological and Prognostic Characteristics in Dedifferentiated/Poorly Differentiated Chordomas: A Pooled Analysis of Individual Patient Data From 58 Studies and Comparison With Conventional Chordomas

    Clinicopathological and Prognostic Characteristics in Dedifferentiated/Poorly Differentiated Chordomas: A Pooled Analysis of Individual Patient Data From 58 Studies and Comparison... by Fu-Sheng Liu, Fu-Sheng Liu, Bo-Wen Zheng, Bo-Wen Zheng, Tao-Lan Zhang, Jing Li, Guo-Hua Lv, Yi-Guo Yan, Wei Huang, Ming-Xiang Zou

    Published 2021-08-01
    Get full text
    Article
  5. 5
    Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients

    Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients by Chao Xia, Chao Xia, Wei Huang, Yun-Liang Chen, Hai-Bin Fu, Ming Tang, Tao-Lan Zhang, Jing Li, Guo-Hua Lv, Yi-Guo Yan, Zhi-Hua Ouyang, Nvzhao Yao, Cheng Wang, Ming-Xiang Zou

    Published 2022-01-01
    Get full text
    Article
  6. 6
    Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma

    Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma by Wei Huang, Wei Huang, Yi-Guo Yan, Wen-Jun Wang, Zhi-Hua Ouyang, Xue-Lin Li, Tao-Lan Zhang, Xiao-Bin Wang, Bing Wang, Guo-Hua Lv, Jing Li, Ming-Xiang Zou, Ming-Xiang Zou

    Published 2020-10-01
    Get full text
    Article
  7. 7
    Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients

    Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients by Chao Xia, Chao Xia, Wei Huang, Yun-Liang Chen, Hai-Bin Fu, Ming Tang, Tao-Lan Zhang, Jing Li, Guo-Hua Lv, Yi-Guo Yan, Zhi-Hua Ouyang, Nvzhao Yao, Cheng Wang, Ming-Xiang Zou

    Published 2023-04-01
    Get full text
    Article

Search Tools: